home / stock / medxf / medxf news

MEDXF News and Press, Medexus Pharmaceuticals Inc From 03/01/21

Stock Information
Company Name: Medexus Pharmaceuticals Inc
Stock Symbol: MEDXF
Market: OTC
Website: medexusinc.com
Menu
MEDXF MEDXF Quote MEDXF Short MEDXF News MEDXF Articles MEDXF Message Board
Get MEDXF Alerts

News, Short Squeeze, Breakout and More Instantly...
MEDXF - Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021

TORONTO, CHICAGO and MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced its financial and operating results for the three and nine mont...
MEDXF - Medexus Announces Expanded Availability of Gleolan® in Canada

TORONTO and CHICAGO and MONTREAL, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it has initiated the commercial launch of Gleolan® ...

MEDXF - Medexus Schedules Third Quarter Fiscal 2021 Conference Call

TORONTO and CHICAGO and MONTREAL, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it plans to host a conference call at 8:00 AM Eastern Ti...

MEDXF - Medexus Announces Closing of $32.5 Million Public Offering, Including Exercise in Full of Over-Allotment Option

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, CHICAGO and MONTREAL, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (Frankfurt: P731) announce...
MEDXF - Medexus to Present at the Winter Wonderland Conference- Best Ideas from the Buy-Side

TORONTO, CHICAGO and MONTREAL, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it will be presenting at the Winter Wonderland Conference, ...

MEDXF - Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell Transplantation, Treosulfan, in the United States

Orphan Designated Drug with August 2021 PDUFA date Management to host conference call at 10:00 AM Eastern Time on February 3, 2021 and Key Opinion Leader webinar to be held at 2:00 PM Eastern Time on February 5, 2021 TORONTO and CHICAGO and MONTREAL and WEDEL, German...

MEDXF - Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA®

TORONTO, CHICAGO and MONTREAL, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it has renewed and expanded its distribution agreement for ...
MEDXF - Medexus Submits Application to List on the Nasdaq

TORONTO, CHICAGO and MONTREAL, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it has submitted its application to list on The Nasdaq Capi...

MEDXF - Medexus Engages Independent Trading Group for Market Making Services

TORONTO and CHICAGO and MONTREAL, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it has engaged Independent Trading Group (ITG), Inc. (&#...

MEDXF - Keynotes, Educational Panels and 42 Canadian-Listed Public Companies to Present at the SNN Network Canada Virtual Event on January 6-7, 2021

LOS ANGELES, CA / ACCESSWIRE / January 5, 2021 / The SNN Network Canada Virtual Event will take place on January 6-7, 2021, where 42 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. Kicking off the SNN Network Canada Virtu...
Previous 10 Next 10